| Literature DB >> 31357749 |
Hye Jin Park1, Huiyoung Kwon1, Ji Hye Lee2, Eunbi Cho1, Young Choon Lee1,3, Minho Moon4, Mira Jun3,5, Dong Hyun Kim1,3, Ji Wook Jung6.
Abstract
Alzheimer's disease (AD) is a progressive and most frequently diagnosed neurodegenerative disorder. However, there is still no drug preventing the progress of this disorder. β-Amyrin, an ingredient of the surface wax of tomato fruit and dandelion coffee, is previously reported to ameliorate memory impairment induced by cholinergic dysfunction. Therefore, we tested whether β-amyrin can prevent AD-like pathology. β-Amyrin blocked amyloid β (Aβ)-induced long-term potentiation (LTP) impairment in the hippocampal slices. Moreover, β-amyrin improved Aβ-induced suppression of phosphatidylinositol-3-kinase (PI3K)/Akt signaling. LY294002, a PI3K inhibitor, blocked the effect of β-amyrin on Aβ-induced LTP impairment. In in vivo experiments, we observed that β-amyrin ameliorated object recognition memory deficit in Aβ-injected AD mice model. Moreover, neurogenesis impairments induced by Aβ was improved by β-amyrin treatment. Taken together, β-amyrin might be a good candidate of treatment or supplement for AD patients.Entities:
Keywords: Alzheimer's disease; Amyloid β; Synaptic plasticity; β-amyrin
Year: 2019 PMID: 31357749 DOI: 10.4062/biomolther.2019.024
Source DB: PubMed Journal: Biomol Ther (Seoul) ISSN: 1976-9148 Impact factor: 4.634